Skip to main content
Erschienen in: Familial Cancer 3/2011

01.09.2011

Case studies in the diagnosis and management of Peutz-Jeghers syndrome

verfasst von: Douglas Riegert-Johnson, Maegan Roberts, Ferga C. Gleeson, Murli Krishna, Lisa Boardman

Erschienen in: Familial Cancer | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Peutz-Jeghers syndrome (PJS) is a rare genetic disorder characterized by melanotic macules, gastrointestinal polyps and increased cancer risks. We discuss several common scenarios encountered in the diagnosis and management of PJS patients. If the diagnosis is unclear, all pathological material should be re-evaluated by an expert gastrointestinal pathologist. The PJS discussion email list-serve (patient managed) and the peutz-jeghers.com, geneclinics.org, stk11.com websites are useful resources for patients. Cancer surveillance is accepted as a method to increase survival for PJS patients, thus all PJS patients should be prescribed an individualized surveillance plan based on personal and family history as well as available health care resources while taking into consideration the preferences of the patient. Several recent incremental improvements in PJS care have been made including the use of magnetic resonance enterography (MRE) and double balloon endoscopy (DBE). MRE combines cancer and small intestinal polyp surveillance, which previously had required two or more separate tests. How and when to perform pancreatic cancer surveillance continues to be an unclear area in the management of PJS patients. Endoscopic ultrasound (EUS) is probably the most sensitive investigation for pancreatic cancer detection at an early stage when cure may be possible. However, EUS is limited by variability and false positive results. Female patients with PJS are at risk for two rare cancers that require regular surveillance, adenoma malignum and ovarian sex cord tumors with annular tubules.
Literatur
1.
Zurück zum Zitat Connor J (1895) Aesculapian society of London. Lancet 2:1169 Connor J (1895) Aesculapian society of London. Lancet 2:1169
2.
Zurück zum Zitat Peutz J (1921) Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane. Nederl Maandschr Geneesk 10:134–146 Peutz J (1921) Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane. Nederl Maandschr Geneesk 10:134–146
3.
Zurück zum Zitat Jeghers H, McKusick V, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 241(25):993PubMedCrossRef Jeghers H, McKusick V, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 241(25):993PubMedCrossRef
4.
Zurück zum Zitat Beggs AD, Latchford AR, Vasen HF et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59(7):975–986PubMedCrossRef Beggs AD, Latchford AR, Vasen HF et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59(7):975–986PubMedCrossRef
5.
Zurück zum Zitat van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME (2010) High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 105(6):1258–1264 author reply 1265PubMedCrossRef van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME (2010) High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 105(6):1258–1264 author reply 1265PubMedCrossRef
6.
Zurück zum Zitat de Leng WW, Westerman AM, Weterman MA et al (2007) Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity. J Clin Pathol 60(4):392–396PubMedCrossRef de Leng WW, Westerman AM, Weterman MA et al (2007) Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity. J Clin Pathol 60(4):392–396PubMedCrossRef
7.
Zurück zum Zitat Oncel M, Remzi FH, Church JM, Goldblum JR, Zutshi M, Fazio VW (2003) Course and follow-up of solitary Peutz-Jeghers polyps: a case series. Int J Colorectal Dis 18(1):33–35PubMedCrossRef Oncel M, Remzi FH, Church JM, Goldblum JR, Zutshi M, Fazio VW (2003) Course and follow-up of solitary Peutz-Jeghers polyps: a case series. Int J Colorectal Dis 18(1):33–35PubMedCrossRef
8.
Zurück zum Zitat Sweet K, Willis J, Zhou XP et al (2005) Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294(19):2465–2473PubMedCrossRef Sweet K, Willis J, Zhou XP et al (2005) Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294(19):2465–2473PubMedCrossRef
9.
Zurück zum Zitat You YN, Wolff BG, Boardman LA, Riegert-Johnson DL, Qin R (2010) Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer You YN, Wolff BG, Boardman LA, Riegert-Johnson DL, Qin R (2010) Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer
10.
Zurück zum Zitat van Lier MG, Mathus-Vliegen EM, van Leerdam ME et al (2010) Quality of life and psychological distress in patients with Peutz-Jeghers syndrome. Clin Genet 78(3):219–226PubMedCrossRef van Lier MG, Mathus-Vliegen EM, van Leerdam ME et al (2010) Quality of life and psychological distress in patients with Peutz-Jeghers syndrome. Clin Genet 78(3):219–226PubMedCrossRef
11.
Zurück zum Zitat Woo A, Sadana A, Mauger DT, Baker MJ, Berk T, McGarrity TJ (2009) Psychosocial impact of Peutz-Jeghers syndrome. Fam Cancer 8(1):59–65PubMedCrossRef Woo A, Sadana A, Mauger DT, Baker MJ, Berk T, McGarrity TJ (2009) Psychosocial impact of Peutz-Jeghers syndrome. Fam Cancer 8(1):59–65PubMedCrossRef
12.
Zurück zum Zitat Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209–3215PubMedCrossRef Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209–3215PubMedCrossRef
13.
Zurück zum Zitat Rubenstein JH, Scheiman JM, Anderson MA (2007) A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 7(5–6):514–525PubMedCrossRef Rubenstein JH, Scheiman JM, Anderson MA (2007) A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 7(5–6):514–525PubMedCrossRef
14.
Zurück zum Zitat Latchford A, Greenhalf W, Vitone LJ, Neoptolemos JP, Lancaster GA, Phillips RK (2006) Peutz-Jeghers syndrome and screening for pancreatic cancer. Br J Surg 93(12):1446–1455PubMedCrossRef Latchford A, Greenhalf W, Vitone LJ, Neoptolemos JP, Lancaster GA, Phillips RK (2006) Peutz-Jeghers syndrome and screening for pancreatic cancer. Br J Surg 93(12):1446–1455PubMedCrossRef
15.
Zurück zum Zitat Topazian M, Enders F, Kimmey M et al (2007) Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc 66(1):62–67PubMedCrossRef Topazian M, Enders F, Kimmey M et al (2007) Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc 66(1):62–67PubMedCrossRef
16.
Zurück zum Zitat Canto MI, Goggins M, Yeo CJ et al (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2(7):606–621PubMedCrossRef Canto MI, Goggins M, Yeo CJ et al (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2(7):606–621PubMedCrossRef
17.
Zurück zum Zitat Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169(22):2078–2086PubMedCrossRef Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169(22):2078–2086PubMedCrossRef
18.
Zurück zum Zitat Gupta A, Postgate AJ, Burling D et al (2010) A prospective study of MR enterography versus capsule endoscopy for the surveillance of adult patients with Peutz-Jeghers syndrome. AJR Am J Roentgenol 195(1):108–116PubMedCrossRef Gupta A, Postgate AJ, Burling D et al (2010) A prospective study of MR enterography versus capsule endoscopy for the surveillance of adult patients with Peutz-Jeghers syndrome. AJR Am J Roentgenol 195(1):108–116PubMedCrossRef
19.
Zurück zum Zitat Spigelman AD, Murday V, Phillips RK (1989) Cancer and the Peutz-Jeghers syndrome. Gut 30(11):1588–1590PubMedCrossRef Spigelman AD, Murday V, Phillips RK (1989) Cancer and the Peutz-Jeghers syndrome. Gut 30(11):1588–1590PubMedCrossRef
20.
Zurück zum Zitat Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE (1989) Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 13(9):717–729PubMedCrossRef Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE (1989) Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 13(9):717–729PubMedCrossRef
21.
Zurück zum Zitat Tsuruchi N, Tsukamoto N, Kaku T, Kamura T, Nakano H (1994) Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome. Gynecol Oncol 54(2):232–236PubMedCrossRef Tsuruchi N, Tsukamoto N, Kaku T, Kamura T, Nakano H (1994) Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome. Gynecol Oncol 54(2):232–236PubMedCrossRef
22.
Zurück zum Zitat Young RH, Scully RE (1982) Ovarian sex cord-stromal tumors: recent progress. Int J Gynecol Pathol 1(1):101–123PubMedCrossRef Young RH, Scully RE (1982) Ovarian sex cord-stromal tumors: recent progress. Int J Gynecol Pathol 1(1):101–123PubMedCrossRef
23.
Zurück zum Zitat Lele SM, Sawh RN, Zaharopoulos P et al (2000) Malignant ovarian sex cord tumor with annular tubules in a patient with Peutz-Jeghers syndrome: a case report. Mod Pathol 13(4):466–470PubMedCrossRef Lele SM, Sawh RN, Zaharopoulos P et al (2000) Malignant ovarian sex cord tumor with annular tubules in a patient with Peutz-Jeghers syndrome: a case report. Mod Pathol 13(4):466–470PubMedCrossRef
24.
Zurück zum Zitat Rodu B, Martinez MG Jr (1984) Peutz-Jeghers syndrome and cancer. Oral Surg Oral Med Oral Pathol 58(5):584–588PubMedCrossRef Rodu B, Martinez MG Jr (1984) Peutz-Jeghers syndrome and cancer. Oral Surg Oral Med Oral Pathol 58(5):584–588PubMedCrossRef
25.
Zurück zum Zitat Barker D, Sharma R, McIndoe A et al (2010) An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome. Int J Gynecol Pathol 29(1):27–32PubMedCrossRef Barker D, Sharma R, McIndoe A et al (2010) An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome. Int J Gynecol Pathol 29(1):27–32PubMedCrossRef
26.
Zurück zum Zitat Riegert-Johnson DL, Gleeson FC, Westra W, Hefferon T, Wong Kee Song LM, Spurck L, Boardman LA (2010) Peutz-Jeghers syndrome. Cancer Syndromes www.stk11.com Riegert-Johnson DL, Gleeson FC, Westra W, Hefferon T, Wong Kee Song LM, Spurck L, Boardman LA (2010) Peutz-Jeghers syndrome. Cancer Syndromes www.​stk11.​com
27.
Zurück zum Zitat Aaltonen LA, Billaud M, Järvinen H, Jass JR, Gruber SB (2000) World health organization classification of tumours, pathology and genetics, tumours of the digestive system. IRAC press, Lyon Aaltonen LA, Billaud M, Järvinen H, Jass JR, Gruber SB (2000) World health organization classification of tumours, pathology and genetics, tumours of the digestive system. IRAC press, Lyon
28.
29.
Zurück zum Zitat Postgate A, Despott E, Burling D et al (2008) Significant small-bowel lesions detected by alternative diagnostic modalities after negative capsule endoscopy. Gastrointest Endosc 68(6):1209–1214PubMedCrossRef Postgate A, Despott E, Burling D et al (2008) Significant small-bowel lesions detected by alternative diagnostic modalities after negative capsule endoscopy. Gastrointest Endosc 68(6):1209–1214PubMedCrossRef
Metadaten
Titel
Case studies in the diagnosis and management of Peutz-Jeghers syndrome
verfasst von
Douglas Riegert-Johnson
Maegan Roberts
Ferga C. Gleeson
Murli Krishna
Lisa Boardman
Publikationsdatum
01.09.2011
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 3/2011
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-011-9438-x

Weitere Artikel der Ausgabe 3/2011

Familial Cancer 3/2011 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.